# Efficacy and Safety of Bromfenac Ophthalmic Solution

> **NCT00585975** · PHASE2 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 568 (actual)

## Conditions studied

- Cataract Surgery

## Interventions

- **DRUG:** bromfenac ophthalmic solution

## Key facts

- **NCT ID:** NCT00585975
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-07
- **Final completion:** —
- **Target enrollment:** 568 (ACTUAL)
- **Last updated:** 2013-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00585975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00585975, "Efficacy and Safety of Bromfenac Ophthalmic Solution". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00585975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*